Silo Pharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Silo Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Silo Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$929K, a 40.7% decline year-over-year.
  • Silo Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.78M, a 10.8% increase year-over-year.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.7M, a 5.32% increase from 2022.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.91M, a 200% decline from 2021.
  • Silo Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $3.9M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.78M -$929K -$269K -40.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$3.51M -$932K +$81.2K +8.01% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$3.6M -$802K +$105K +11.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$3.7M -$1.12M +$542K +32.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$4.24M -$660K +$323K +32.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$4.57M -$1.01M -$355K -53.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$4.21M -$906K -$302K -50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$3.91M -$1.66M -$574K -52.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$3.33M -$983K -$7.37M -115% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4.03M -$658K -$196K -42.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 $4.23M -$604K +$327K +35.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 $3.9M -$1.09M -$299K -37.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $4.2M $6.39M +$7.02M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.82M -$462K +$913K +66.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$3.73M -$931K -$692K -290% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$3.04M -$790K -$408K -107% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$2.63M -$634K -$368K -139% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$2.26M -$1.38M -$1.13M -468% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.13M -$239K -$115K -93.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$1.01M -$382K +$90.9K +19.2% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
Q3 2019 -$1.1M -$265K -$67.3K -34% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$1.04M -$242K +$73.7K +23.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$1.11M -$124K -$141K -804% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$969K -$473K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$198K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$316K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $17.5K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2013 -$63.3K -$5.74K +$2.81K +32.8% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 -$66.1K -$22.5K -$16.8K -297% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$49.3K -$22.9K -$9.84K -75.5% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q4 2012 -$39.4K -$12.2K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$8.55K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.67K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$13K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.